Chemoinformaics analysis of Ethyl 4-hydroxy-3-methylbut-2-enoate
| Molecular Weight | 144.17 | nRot | 3 |
| Heavy Atom Molecular Weight | 132.074 | nRig | 2 |
| Exact Molecular Weight | 144.079 | nRing | 0 |
| Solubility: LogS | -0.211 | nHRing | 0 |
| Solubility: LogP | 0.648 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 22.0975 |
| nHD | 1 | BPOL | 14.6425 |
| QED | 0.432 |
| Synth | 2.88 |
| Natural Product Likeliness | 0.928 |
| NR-PPAR-gamma | 0.487 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.018 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.408 |
| MDCK | 0.0000559 |
| BBB | 0.99 |
| PPB | 0.444731 |
| VDSS | 0.813 |
| FU | 0.814643 |
| CYP1A2-inh | 0.151 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.039 |
| CYP2c19-sub | 0.623 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.12 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.197 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.26 |
| CL | 10.714 |
| T12 | 0.901 |
| hERG | 0.072 |
| Ames | 0.068 |
| ROA | 0.017 |
| SkinSen | 0.965 |
| Carcinogencity | 0.034 |
| EI | 0.993 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.03 |
| Antiviral | No |
| Prediction | 0.944201 |